Magda specialises in the fields of life sciences and chemistry, handling a wide range of biotechnology, pharmaceutical and chemical subject matter including biopharmaceuticals, personalised medicine, antibody and peptide therapeutics, antimicrobial formulations, sequencing, gene silencing, nutraceuticals, plant biotechnology, microfluidics, diagnostics, medical devices, polymer compositions, consumer goods and healthcare products.
Her work involves patent drafting and prosecution, EPO oppositions and appeals, patent landscape analyses for freedom to operate and patentability, infringement risk assessments and due diligence, and Supplementary Protections Certificates. She has been working for clients ranging from individual inventors and academia to large multinationals.
Magda has a technical background in chemistry (PhD) and biotechnology (MSc). Prior to joining the patent attorney profession in 2010, Magda worked as a senior scientist at the University of Cambridge and lead research and development of point-of-care molecular diagnostics. As a co-founder of a spin-off company from the University of Cambridge, Magda worked on building and managed global IP portfolio of patents and trademarks. Her work as an in-house IP manager included invention harvesting and coordinating national and foreign filings and prosecution strategies. Related inventions received the EPO European Inventor Award in the SME category.
Simple Amplification-Based Assay: A Nucleic Acid Based Point-of-Care Platform for HIV-1 Testing; Journal of Infectious Diseases (2010), 201 Suppl. 1: S65-72. DOI: 10.1086/650385
A new generation of point-of-care rapid tests; Horizons in medicine 20, Royal College of Physicians, December 2008
Sample preparation: a challenge in the development of point-of-care nucleic acid-based assays for resource-limited settings; Analyst (2007), 132: 1193-1199
Simultaneous Visual Detection of Multiple Viral Amplicons by Dipstick Assay; J Clinical Microbiology (2005), 43(8): 4015–4021